366 related articles for article (PubMed ID: 16211660)
1. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
2. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
3. Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.
Palit P; Paira P; Hazra A; Banerjee S; Gupta AD; Dastidar SG; Mondal NB
Eur J Med Chem; 2009 Feb; 44(2):845-53. PubMed ID: 18538452
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents.
Chandra N; Pandey S; Ramesh ; Suryawanshi SN; Gupta S
Eur J Med Chem; 2006 Jun; 41(6):779-85. PubMed ID: 16697490
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
8. Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components.
Desrivot J; Herrenknecht C; Ponchel G; Garbi N; Prina E; Fournet A; Bories C; Figadère B; Hocquemiller R; Loiseau PM
Biomed Pharmacother; 2007 Aug; 61(7):441-50. PubMed ID: 17459651
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
12. Constituents of Tinospora sinensis and their antileishmanial activity against Leishmania donovani.
Maurya R; Gupta P; Chand K; Kumar M; Dixit P; Singh N; Dube A
Nat Prod Res; 2009; 23(12):1134-43. PubMed ID: 19662579
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity.
Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S
Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
15. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis.
Chakrabarti G; Basu A; Manna PP; Mahato SB; Mandal NB; Bandyopadhyay S
J Antimicrob Chemother; 1999 Mar; 43(3):359-66. PubMed ID: 10223591
[TBL] [Abstract][Full Text] [Related]
16. [Antileishmanial activity of five 2- or 3- quinolines by enyne group].
Seck M; Desrivot J; Bories C; Loiseau P; Franck X; Hocquemiller R; Figadere B; Peyrat JF; Provot O; Brion JD; Alami M
Dakar Med; 2005; 50(3):172-5. PubMed ID: 17633005
[TBL] [Abstract][Full Text] [Related]
17. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
Kumar A; Katiyar SB; Gupta S; Chauhan PM
Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
Agarwal KC; Sharma V; Shakya N; Gupta S
Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
[TBL] [Abstract][Full Text] [Related]
19. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes.
Muniaraj M; Sinha PK; Das P
Trop Biomed; 2010 Dec; 27(3):657-61. PubMed ID: 21399608
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of original amidoximes as antileishmanial agents.
Bouhlel A; Curti C; Dumètre A; Laget M; Crozet MD; Azas N; Vanelle P
Bioorg Med Chem; 2010 Oct; 18(20):7310-20. PubMed ID: 20833057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
